Aldebaran Capital’s Eli Lilly LLY Stock Holding History

Aldebaran Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.28M	Sell	9,007 -25	-0.3%	-$25.3K	6.33%	4
2025 Q4	$9.71M	Buy	9,032 +1,249	+16%	+$1.19M	8.7%	2
2025 Q3	$5.94M	Hold	7,783	–	–	5.45%	5
2025 Q2	$6.07M	Hold	7,783	–	–	5.99%	5
2025 Q1	$6.43M	Hold	7,783	–	–	6.08%	5
2024 Q4	$6.01M	Hold	7,783	–	–	5.71%	6
2024 Q3	$6.9M	Hold	7,783	–	–	6.29%	5
2024 Q2	$7.05M	Hold	7,783	–	–	6.56%	5
2024 Q1	$6.05M	Hold	7,783	–	–	5.77%	5
2023 Q4	$4.54M	Hold	7,783	–	–	4.64%	9
2023 Q3	$4.18M	Sell	7,783 -50	-0.6%	-$25.8K	4.26%	9
2023 Q2	$3.67M	Hold	7,833	–	–	3.77%	10
2023 Q1	$2.69M	Sell	7,833 -50	-0.6%	-$16.9K	2.75%	13
2022 Q4	$2.88M	Buy	+7,883	New	+$2.79M	2.98%	13

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aldebaran Capital's LLY Position: Q1 2026 in Review

Aldebaran Capital reduced its Eli Lilly (LLY) stake by 0.28% in Q1 2026, selling an estimated $25.3K and leaving 9,007 shares worth $8.28M. The position accounts for 6.33% of the portfolio, ranked #4.

Aldebaran Capital first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $9.71M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Aldebaran Capital held 9,007 shares of Eli Lilly worth $8.28M as of Q1 2026.
Aldebaran Capital sold 25 Eli Lilly shares in Q1 2026, an estimated $25.3K.
Eli Lilly made up 6.33% of Aldebaran Capital's portfolio in Q1 2026, its #4 holding.
Aldebaran Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
Aldebaran Capital's Eli Lilly position peaked at $9.71M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Aldebaran Capital's 13F filing for Q1 2026, filed 7 May 2026.